COVID-19 and immune checkpoint inhibitors: initial considerations

COVID-19 infections are characterized by inflammation of the lungs and other organs that ranges from mild and asymptomatic to fulminant and fatal. Patients who are immunocompromised and those with cardiopulmonary comorbidities appear to be particularly afflicted by this illness. During pandemic cond...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Sullivan, Ryan J, Johnson, Douglas B, Rini, Brian I, Neilan, Tomas G, Lovly, Christine M, Moslehi, Javid J, Reynolds, Kerry L
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7246104/
https://ncbi.nlm.nih.gov/pubmed/32434790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000933
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky